The company said its 2025 fiscal second-quarter sales for Q2, which ended on April 30, rose 5% from $651 million a year earlier to $683 million. It cited the acquisition impact of 8% as offsetting an organic sales decline of 2% and currency translation impact of less than 1%.

1. 01

   The company said its 2025 fiscal second-quarter sales for Q2, which ended on April 30, rose 5% from $651 million a year earlier to $683 million. It cited the acquisition impact of 8% as offsetting an organic sales decline of 2% and currency translation impact of less than 1%.

2. 02

   Nordson said its net income for Q2 was $112 million ($1.97 per diluted share), down from $118 million ($2.05) a year earlier. Adjusted diluted earnings per share, which exclude restructuring costs and acquisition-related amortization, were $2.42, up 3% from $2.34 a year earlier.

3. 03

   The company said Industrial Precision Solutions sales for Q2 fell 8% to $319 million, while Medical and Fluid Solutions sales rose 20% to $203 million, with the acquisition contributing 30%. Advanced Technology Solutions sales increased 18% organically to $161 million.

4. 04

   Based on current visibility and order entry trends, the company expects fiscal 2025 Q3 sales of $710 to $750 million and adjusted diluted earnings per share of $2.55 to $2.75. The company also said its backlog rose approximately 5% from the prior quarter.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.